IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0001952.html
   My bibliography  Save this article

Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults

Author

Listed:
  • Jinhong Hu
  • Zhihui Chen
  • Jun Gu
  • Mobin Wan
  • Qian Shen
  • Marie-Paule Kieny
  • Jia He
  • Zhen Li
  • Qingfeng Zhang
  • Zarifah Hussain Reed
  • Yongmei Zhu
  • Wenjie Li
  • Yang Cao
  • Li Qu
  • Zhifang Cao
  • Qiang Wang
  • Haitao Liu
  • Xuegong Pan
  • Xiudong Huang
  • Dongmei Zhang
  • Xiangyang Xue
  • Weiqing Pan

Abstract

Background: The P. falciparum chimeric protein 2.9 (PfCP-2.9) consisting of the sequences of MSP1-19 and AMA-1 (III) is a malaria vaccine candidate that was found to induce inhibitory antibodies in rabbits and monkeys. This was a phase I randomized, single-blind, placebo-controlled, dose-escalation study to evaluate the safety and immunogenicity of the PfCP-2.9 formulated with a novel adjuvant Montanide ISA720. Fifty-two subjects were randomly assigned to 4 dose groups of 10 participants, each receiving the test vaccine of 20, 50, 100, or 200 µg respectively, and 1 placebo group of 12 participants receiving the adjuvant only. Methods and Findings: The vaccine formulation was shown to be safe and well-tolerated, and none of the participants withdrew. The total incidence of local adverse events (AEs) was 75%, distributed among 58% of the placebo group and 80% of those vaccinated. Among the vaccinated, 65% had events that were mild and 15% experienced moderate AEs. Almost all systemic adverse reactions observed in this study were graded as mild and required no therapy. The participants receiving the test vaccine developed detectable antibody responses which were boosted by the repeated vaccinations. Sixty percent of the vaccinated participants had high ELISA titers (>1∶10,000) of antigen-specific antibodies which could also recognize native parasite proteins in an immunofluorescence assay (IFA). Conclusion: This study is the first clinical trial for this candidate and builds on previous investigations supporting PfCP-2.9/ISA720 as a promising blood-stage malaria vaccine. Results demonstrate safety, tolerability (particularly at the lower doses tested) and immunogenicity of the formulation. Further clinical development is ongoing to explore optimizing the dose and schedule of the formulation to decrease reactogenicity without compromising immunogenicity. Trial Registration: Chinese State Food and Drug Administration (SFDA) 2002SL0046; Controlled-Trials.com ISRCTN66850051

Suggested Citation

  • Jinhong Hu & Zhihui Chen & Jun Gu & Mobin Wan & Qian Shen & Marie-Paule Kieny & Jia He & Zhen Li & Qingfeng Zhang & Zarifah Hussain Reed & Yongmei Zhu & Wenjie Li & Yang Cao & Li Qu & Zhifang Cao & Qi, 2008. "Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults," PLOS ONE, Public Library of Science, vol. 3(4), pages 1-14, April.
  • Handle: RePEc:plo:pone00:0001952
    DOI: 10.1371/journal.pone.0001952
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001952
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001952&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0001952?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Robert W. Snow & Carlos A. Guerra & Abdisalan M. Noor & Hla Y. Myint & Simon I. Hay, 2005. "The global distribution of clinical episodes of Plasmodium falciparum malaria," Nature, Nature, vol. 434(7030), pages 214-217, March.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ruth D Ellis & Laura B Martin & Donna Shaffer & Carole A Long & Kazutoyo Miura & Michael P Fay & David L Narum & Daming Zhu & Gregory E D Mullen & Siddhartha Mahanty & Louis H Miller & Anna P Durbin, 2010. "Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults," PLOS ONE, Public Library of Science, vol. 5(1), pages 1-9, January.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. repec:hrv:hksfac:5341873 is not listed on IDEAS
    2. Florence Burté & Biobele J Brown & Adebola E Orimadegun & Wasiu A Ajetunmobi & Francesca Battaglia & Barry K Ely & Nathaniel K Afolabi & Dimitrios Athanasakis & Francis Akinkunmi & Olayinka Kowobari &, 2012. "Severe Childhood Malaria Syndromes Defined by Plasma Proteome Profiles," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-11, December.
    3. Denis Valle & James Clark, 2013. "Improving the Modeling of Disease Data from the Government Surveillance System: A Case Study on Malaria in the Brazilian Amazon," PLOS Computational Biology, Public Library of Science, vol. 9(11), pages 1-14, November.
    4. Samantha Rawlings, 2012. "Gender, race, and heterogeneous scarring and selection effects of epidemic malaria on human capital," Economics Discussion Papers em-dp2012-01, Department of Economics, University of Reading.
    5. Denis Valle & James S Clark & Kaiguang Zhao, 2011. "Enhanced Understanding of Infectious Diseases by Fusing Multiple Datasets: A Case Study on Malaria in the Western Brazilian Amazon Region," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-13, November.
    6. Saira Baloch & Xiaofang Pei, 2019. "Elucidate the Renal Biochemical Factors in Patients with Malaria," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 23(4), pages 17640-17643, December.
    7. Margaret Kweku & Dongmei Liu & Martin Adjuik & Fred Binka & Mahmood Seidu & Brian Greenwood & Daniel Chandramohan, 2008. "Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial," PLOS ONE, Public Library of Science, vol. 3(12), pages 1-12, December.
    8. Stefan Dongus & Constanze Pfeiffer & Emmy Metta & Selemani Mbuyita & Brigit Obrist, 2010. "Building multi†layered resilience in a malaria control programme in Dar es Salaam, Tanzania," Progress in Development Studies, , vol. 10(4), pages 309-324, October.
    9. Philip Bejon & Edna Ogada & Tabitha Mwangi & Paul Milligan & Trudie Lang & Greg Fegan & Sarah C Gilbert & Norbert Peshu & Kevin Marsh & Adrian VS Hill, 2007. "Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya," PLOS ONE, Public Library of Science, vol. 2(8), pages 1-5, August.
    10. Peter W Gething & Anand P Patil & Simon I Hay, 2010. "Quantifying Aggregated Uncertainty in Plasmodium falciparum Malaria Prevalence and Populations at Risk via Efficient Space-Time Geostatistical Joint Simulation," PLOS Computational Biology, Public Library of Science, vol. 6(4), pages 1-12, April.
    11. Laurens Manning & Moses Laman & Wendy A Davis & Timothy M E Davis, 2014. "Clinical Features and Outcome in Children with Severe Plasmodium falciparum Malaria: A Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(2), pages 1-11, February.
    12. Simon I Hay & Robert W Snow, 2006. "The Malaria Atlas Project: Developing Global Maps of Malaria Risk," PLOS Medicine, Public Library of Science, vol. 3(12), pages 1-5, December.
    13. Alessandro Tarozzi & Aprajit Mahajan & Joanne Yoong & Brian Blackburn, 2009. "Commitment Mechanisms and Compliance with Health-Protecting Behavior: Preliminary Evidence from Orissa, India," American Economic Review, American Economic Association, vol. 99(2), pages 231-235, May.
    14. William C. Clark & Nicole A. Szlezak & Suerie Moon & Barry R. Bloom & Gerald T. Keusch & Catherine M. Michaud & Dean T. Jamison & Julio Frenk & Wen L. Kilama, 2010. "The Global Health System: Institutions in a Time of Transition," CID Working Papers 193, Center for International Development at Harvard University.
    15. Yakubu, D. P & Kamji, N. B & Dawet, A, 2018. "Prevalence of Malaria Among Pregnant Women Attending Antenatal Care at Faith Alive Foundation, Jos, Plateau State, Nigeria," Noble International Journal of Scientific Research, Noble Academic Publsiher, vol. 2(4), pages 19-26, April.
    16. repec:rdg:wpaper:em-dp2012-01 is not listed on IDEAS
    17. Ricardo Águas & Lisa J White & Robert W Snow & M Gabriela M Gomes, 2008. "Prospects for Malaria Eradication in Sub-Saharan Africa," PLOS ONE, Public Library of Science, vol. 3(3), pages 1-6, March.
    18. Clark, William C. & Szlezak, Nicole Alexandra & Moon, Suerie & Bloom, Barry R. & Keusch, Gerald T. & Michaud, Catherine M. & Jamison, Dean T. & Frenk, Julio & Kilama, Wen L., 2017. "The Global Health System: Institutions in a Time of Transition," Scholarly Articles 32062576, Harvard Kennedy School of Government.
    19. Sean M Moore & Andrew Monaghan & Kevin S Griffith & Titus Apangu & Paul S Mead & Rebecca J Eisen, 2012. "Improvement of Disease Prediction and Modeling through the Use of Meteorological Ensembles: Human Plague in Uganda," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-11, September.
    20. Sanjay G. Reddy & Antoine Heuty, 2006. "Achieving the Millennium Development Goals: What’s wrong with existing analytical models?," Working Papers 30, United Nations, Department of Economics and Social Affairs.
    21. Matteo Pedercini & Santiago Movilla Blanco & Birgit Kopainsky, 2011. "Application of the Malaria Management Model to the Analysis of Costs and Benefits of DDT versus Non-DDT Malaria Control," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-12, November.
    22. Lesong Conteh & Edith Patouillard & Margaret Kweku & Rosa Legood & Brian Greenwood & Daniel Chandramohan, 2010. "Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-11, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0001952. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.